Sheffield Kidney Institute, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, United Kingdom.
Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, United Kingdom.
Bone. 2021 Jan;142:115689. doi: 10.1016/j.bone.2020.115689. Epub 2020 Oct 14.
Bone biopsy is the gold standard test to diagnose renal osteodystrophy (ROD). There is a preference to perform bone biopsy during renal transplantation but tetracycline bone labelling is usually not possible. We aimed to test if histomorphometry static parameters can identify low and high bone turnover as assessed by dynamic measurement using double tetracycline labelling.
43 CKD stages 4-5D had trans-iliac bone biopsy using a 4 mm Jamshidi trephine and needle after tetracycline labelling. Quantitative histomorphometry was performed using the Bioquant Osteo histomorphometry system. Normal bone turnover was defined as bone formation rate/bone surface (BFR/BS) of 18-38 μm/μm/year. Static parameters of bone turnover included osteoblast surface/bone surface (Ob.S/BS, %), osteoclast surface/bone surface (Oc.S/BS, %) and erosion surface/bone surface (ES/BS, %). Receiver operating characteristics (ROC) analysis was used to evaluate diagnostic accuracy of these static parameters for low and high bone turnover (based on BFR/BS).
Median (IQR) for BFR/BS in this study was 32.12 (17.76-48.25) μm/μm/year. 26% of patients had low, 34% had normal and 40% had high bone turnover. The area under the ROC curve (AUC) for Ob.S/BS, Oc.S/BS and ES/BS were non-significant indicating poor accuracy for identifying low bone turnover. The AUC for Ob.S/BS was 0.697 (95% CI 0.538 to 0.827) indicating fair accuracy for identifying high bone turnover. Oc.S/BS and ES/BS had non-significant AUCs for high bone turnover.
Static histomorphometry parameters for bone turnover are unable to replace dynamic parameter in diagnosing ROD. Tetracycline bone labelling is still required.
骨活检是诊断肾性骨营养不良(ROD)的金标准检测。肾移植时通常更倾向于进行骨活检,但四环素骨标记通常不可行。我们旨在测试组织形态计量学静态参数是否可以识别低和高骨转换,这些参数通过双四环素标记的动态测量来评估。
43 名 CKD 4-5D 期患者在四环素标记后使用 4mm Jamshidi 环钻和针进行经髂骨活检。使用 Bioquant Osteo 组织形态计量学系统进行定量组织形态计量学分析。正常骨转换定义为骨形成率/骨表面(BFR/BS)为 18-38μm/μm/年。骨转换的静态参数包括成骨细胞表面/骨表面(Ob.S/BS,%)、破骨细胞表面/骨表面(Oc.S/BS,%)和侵蚀表面/骨表面(ES/BS,%)。使用受试者工作特征(ROC)分析评估这些静态参数对低和高骨转换(基于 BFR/BS)的诊断准确性。
本研究中 BFR/BS 的中位数(IQR)为 32.12(17.76-48.25)μm/μm/年。26%的患者骨转换低,34%的患者骨转换正常,40%的患者骨转换高。Ob.S/BS、Oc.S/BS 和 ES/BS 的 ROC 曲线下面积(AUC)无统计学意义,表明这些参数识别低骨转换的准确性较差。Ob.S/BS 的 AUC 为 0.697(95%CI 0.538 至 0.827),表明其识别高骨转换的准确性尚可。Oc.S/BS 和 ES/BS 对高骨转换的 AUC 无统计学意义。
骨转换的静态组织形态计量学参数无法替代动态参数来诊断 ROD。仍需要四环素骨标记。